Imeglimin hydrochloride
盐酸伊美格列明
Report date: 2024/12/11 13:23:47
NMEFirst In Class
Base Information
Drug NameImeglimin hydrochloride
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2021/06/23
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A
Develop Information
Active CompaniesPoxel SaSumitomo Dainippon Pharma Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksWikipedia